Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | JAK3 |
| Variant | A572V |
| Impact List | missense |
| Protein Effect | gain of function |
| Gene Variant Descriptions | JAK3 A572V lies within protein kinase domain 1 of the Jak3 protein (UniProt.org). A572V confers a gain of function to the Jak3 protein, as demonstrated by increased Jak3 autophosphorylation (PMID: 29046866), constitutive phosphorylation of Jak3 and activation of downstream Stat5 (PMID: 22705984, PMID: 35622134), and leads to cytokine-independent proliferation of cultured cells (PMID: 22705984, PMID: 28284718). |
| Associated Drug Resistance | |
| Category Variants Paths |
JAK3 mutant JAK3 act mut JAK3 A572V |
| Transcript | NM_000215.4 |
| gDNA | chr19:g.17837200G>A |
| cDNA | c.1715C>T |
| Protein | p.A572V |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_000215.4 | chr19:g.17837200G>A | c.1715C>T | p.A572V | RefSeq | GRCh38/hg38 |
| NM_000215 | chr19:g.17837200G>A | c.1715C>T | p.A572V | RefSeq | GRCh38/hg38 |
| XM_011527991.3 | chr19:g.17837200G>A | c.1715C>T | p.A572V | RefSeq | GRCh38/hg38 |
| XM_047438786.1 | chr19:g.17837200G>A | c.1715C>T | p.A572V | RefSeq | GRCh38/hg38 |
| NM_000215.3 | chr19:g.17837200G>A | c.1715C>T | p.A572V | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| JAK3 mutant | B-cell acute lymphoblastic leukemia | not applicable | N/A | Guideline | Prognostic | JAK3 mutations are associated with a poor prognosis in patients with B-cell acute lymphoblastic leukemia (NCCN.org). | detail... |
| JAK3 mutant | childhood B-cell acute lymphoblastic leukemia | not applicable | N/A | Guideline | Prognostic | JAK3 mutations are associated with a poor prognosis in pediatric patients with B-cell acute lymphoblastic leukemia (NCCN.org). | detail... |